OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
2628$28.6259

China Life Insurance Co Ltd

Life & Health InsuranceVerified

China Life Insurance Co Ltd exhibits a strong liquidity position, with a price-to-book ratio of 0.36 and a price-to-tangible-book ratio of 0.36, indicating that the company's market value is significantly below its book value. The company's liquidity is further supported by a cash and equivalents balance of CNY 142.37 billion and a free cash flow of CNY 141.19 billion, which provides flexibility for capital allocation and operational needs. Profitability metrics show a return on equity (ROE) of 25.89%, which is well above the industry median for life and health insurers, reflecting strong underwriting and investment performance. However, the return on assets (ROA) of 2.03% is relatively modest, suggesting that the company's asset base is not being utilized as efficiently as its equity. The company's revenue is concentrated in its domestic market, with the Life Insurance Business segment being the largest contributor. The Health and Accident Insurance segments also play significant roles, while the Other Businesses segment includes agency and subsidiary-related income. This geographic and segment concentration may expose the company to regulatory and economic risks specific to China. Looking ahead, the company is expected to maintain a stable growth trajectory, with analysts forecasting a mean price target of CNY 33.47 and a median price target of CNY 33.05. The current market price of CNY 28.62 suggests potential upside, supported by a mean recommendation of 1.71, which is skewed toward "buy" and "strong buy" ratings. Risk factors for the company are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's debt-to-equity ratio of 0.06 indicates a conservative capital structure, and the low dilution risk is further supported by the absence of near-term dilution pressures. Recent events, including the latest financial filings and analyst reports, suggest a stable operating environment for the company. The absence of significant regulatory or operational disruptions in the near term supports the current low-risk assessment.

30-day price · 2628+2.40 (+9.1%)
Low$25.58High$31.84Close$28.72As of21 May, 00:00 UTC
Profile
CompanyChina Life Insurance Co Ltd
Ticker2628.HK
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. China Life Insurance Co Ltd is a China-based company that underwrites life, health, accident, and other types of personal insurance, generating revenue primarily through insurance premiums and investment income.

Classification. China Life Insurance Co Ltd is classified under the Life & Health Insurance industry within the Financials sector, with a confidence level of 0.92 based on verified market data.

China Life Insurance Co Ltd exhibits a strong liquidity position, with a price-to-book ratio of 0.36 and a price-to-tangible-book ratio of 0.36, indicating that the company's market value is significantly below its book value. The company's liquidity is further supported by a cash and equivalents balance of CNY 142.37 billion and a free cash flow of CNY 141.19 billion, which provides flexibility for capital allocation and operational needs. Profitability metrics show a return on equity (ROE) of 25.89%, which is well above the industry median for life and health insurers, reflecting strong underwriting and investment performance. However, the return on assets (ROA) of 2.03% is relatively modest, suggesting that the company's asset base is not being utilized as efficiently as its equity. The company's revenue is concentrated in its domestic market, with the Life Insurance Business segment being the largest contributor. The Health and Accident Insurance segments also play significant roles, while the Other Businesses segment includes agency and subsidiary-related income. This geographic and segment concentration may expose the company to regulatory and economic risks specific to China. Looking ahead, the company is expected to maintain a stable growth trajectory, with analysts forecasting a mean price target of CNY 33.47 and a median price target of CNY 33.05. The current market price of CNY 28.62 suggests potential upside, supported by a mean recommendation of 1.71, which is skewed toward "buy" and "strong buy" ratings. Risk factors for the company are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's debt-to-equity ratio of 0.06 indicates a conservative capital structure, and the low dilution risk is further supported by the absence of near-term dilution pressures. Recent events, including the latest financial filings and analyst reports, suggest a stable operating environment for the company. The absence of significant regulatory or operational disruptions in the near term supports the current low-risk assessment.
Key takeaways
  • China Life Insurance Co Ltd has a strong liquidity position with a price-to-book ratio of 0.36 and a free cash flow of CNY 141.19 billion.
  • The company's ROE of 25.89% is well above the industry median, indicating strong profitability.
  • Revenue is concentrated in the domestic market, with the Life Insurance Business segment being the largest contributor.
  • Analysts project a mean price target of CNY 33.47, suggesting potential upside from the current market price of CNY 28.62.
  • The company's conservative capital structure and low dilution risk support its current low-risk profile.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue
Gross profit
Operating income$185.79B
Net income$154.08B
R&D
SG&A
D&A
SBC
Operating cash flow$459.93B
CapEx
Free cash flow$141.19B
Total assets$7.59T
Total liabilities$7.00T
Total equity$595.21B
Cash & equivalents$142.37B
Long-term debt$35.25B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$185.79B$154.08B$141.19B
FY-1$119.41B$106.94B$95.42B
FY-2$49.88B$46.18B$34.03B
FY-3$74.92B$66.68B$51.15B
FY-4$40.01B$50.77B$33.14B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$7.59T$595.21B$142.37B
FY-1$6.77T$509.68B$85.50B
FY-2$5.80T$477.09B$149.31B
FY-3$5.01T$366.02B$127.59B
FY-4$4.89T$479.06B$60.46B
PeriodOCFCapExFCFSBC
FY0$459.93B$141.19B
FY-1$378.80B$95.42B
FY-2$384.37B-$4.17B$34.03B
FY-3$345.28B-$3.08B$51.15B
FY-4$286.45B-$5.58B$33.14B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$28.62
Market cap$212.97B
Enterprise value$105.84B
P/E1.4
Reported non-GAAP P/E
EV/Revenue
EV/Op income0.6
EV/OCF0.2
P/B0.4
P/Tangible book0.4
Tangible book$595.21B
Net cash$107.12B
Current ratio
Debt/Equity0.1
ROA2.0%
ROE25.9%
Cash conversion3.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Life & Health Insurance · cohort 1 companies
Metric2628Activity
Op margin21.1% medp25 16.7% · p75 136.5%
Net margin10.4% medp25 5.7% · p75 19.8%
Gross margin21.0% medp25 21.0% · p75 21.0%
CapEx / revenue2.4% medp25 2.4% · p75 2.4%
Debt / equity6.0%48.5% medp25 43.7% · p75 53.3%bottom quartile
Observations
IR observations
Mean price target33.47 CNY
Median price target33.05 CNY
High price target44.50 CNY
Low price target14.00 CNY
Mean recommendation1.71 (1=strong buy, 5=strong sell)
Strong-buy count6.00
Buy count10.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate4.22 CNY
Last actual EPS5.45 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-01 03:06 UTC#e44ddc08
Market quoteclose CNY 28.62 · shares 7.44B diluted
no public URL
2026-05-01 03:06 UTC#f3ce42ae
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 03:07 UTCJob: a28b97fa